Literature DB >> 27539294

Initiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort study.

Rachel L McCrea1, Cormac J Sammon1, Irwin Nazareth1, Irene Petersen2.   

Abstract

BACKGROUND: Recent media reports have focused on the large increase in antidepressants dispensed in England. We investigated this, focusing on selective serotonin reuptake inhibitors (SSRIs). AIMS: To examine the rate of initiation of SSRIs over time and changes over time in the duration of prescribing episodes.
METHOD: We estimated initiation and duration of SSRI prescribing from 7 025 802 individuals aged over 18 years and registered with a general practice that contributed data to The Health Improvement Network.
RESULTS: Rates of SSRI initiation increased from 1.03 per 100 person-years in 1995 to 2.15 in 2001, but remained stable from then to 2012. The median duration of prescribing episodes increased from 112 to 169 days for episodes starting in 1995 to 2010.
CONCLUSIONS: Despite media reports describing an increasing rate of antidepressant prescribing, SSRI initiation rates have stabilised since 2001. However, our results suggest that individuals who take SSRIs are receiving treatment for longer. © The Royal College of Psychiatrists 2016.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27539294     DOI： 10.1192/bjp.bp.115.166975

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  10 in total

Review 1.  Guidance for appropriate use of psychotropic drugs in older people.

Authors:  Andreas Capiau; Katrien Foubert; Annemie Somers; Mirko Petrovic
Journal:  Eur Geriatr Med       Date:  2021-01-08       Impact factor: 1.710

2.  A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.

Authors:  George Salaminios; Larisa Duffy; Anthony Ades; Ricardo Araya; Katherine S Button; Rachel Churchill; Tim Croudace; Catherine Derrick; Padraig Dixon; Christopher Dowrick; Simon Gilbody; William Hollingworth; Vivien Jones; Tony Kendrick; David Kessler; Daphne Kounali; Paul Lanham; Alice Malpass; Tim J Peters; Derek Riozzie; Jude Robinson; Debbie Sharp; Laura Thomas; Nicky J Welton; Nicola Wiles; Glyn Lewis
Journal:  Trials       Date:  2017-10-24       Impact factor: 2.279

Review 3.  Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.

Authors:  Willemijn Scholten; Neeltje Batelaan; Anton Van Balkom
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-10

4.  A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial.

Authors:  Larisa Duffy; Faye Bacon; Caroline S Clarke; Yvonne Donkor; Nick Freemantle; Simon Gilbody; Rachael Hunter; Tony Kendrick; David Kessler; Michael King; Paul Lanham; Gemma Lewis; Dee Mangin; Louise Marston; Michael Moore; Irwin Nazareth; Nicola Wiles; Glyn Lewis
Journal:  Trials       Date:  2019-06-03       Impact factor: 2.279

5.  Selective serotonin reuptake inhibitor use in hip fracture patients: a Danish nationwide prevalence study.

Authors:  Stine B Bruun; Irene Petersen; Nickolaj R Kristensen; Deirdre Cronin-Fenton; Alma B Pedersen
Journal:  Acta Orthop       Date:  2018-12-10       Impact factor: 3.717

6.  Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression.

Authors:  Si-Tien Wang; Ian M Anderson; Dominic Mitchell; Scott J Johnson; Aki Shiozawa
Journal:  Clinicoecon Outcomes Res       Date:  2019-03-14

7.  Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population-based study.

Authors:  Nishani Jayasooriya; Jonathan Blackwell; Sonia Saxena; Alex Bottle; Irene Petersen; Hanna Creese; Matthew Hotopf; Richard C G Pollok
Journal:  Aliment Pharmacol Ther       Date:  2022-03-04       Impact factor: 9.524

8.  Initiation of antidepressant medication in people with type 2 diabetes living in the United Kingdom-A retrospective cohort study.

Authors:  Kingshuk Pal; Manuj Sharma; Naaheed M Mukadam; Irene Petersen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-06-10       Impact factor: 2.732

9.  Management of treatment-resistant depression in primary care: a mixed-methods study.

Authors:  Nicola Wiles; Abigail Taylor; Nicholas Turner; Maria Barnes; John Campbell; Glyn Lewis; Jill Morrison; Tim J Peters; Laura Thomas; Katrina Turner; David Kessler
Journal:  Br J Gen Pract       Date:  2018-10       Impact factor: 5.386

10.  Depression, depressive symptoms and treatments in women who have recently given birth: UK cohort study.

Authors:  Irene Petersen; Tomi Peltola; Samuel Kaski; Kate R Walters; Sarah Hardoon
Journal:  BMJ Open       Date:  2018-10-24       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.